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Human bocavirus (HBoV) and HBoV2, two human bo-
cavirus species, were found in 18 and 10 of 235 nasopha-
ryngeal aspirates, respectively, from children hospitalized 
with acute respiratory tract infection. Our results suggest 
that, like HBoV, HBoV2 is distributed worldwide and may be 
associated with respiratory and enteric diseases.
A
cute respiratory tract infection (ARTI) is a leading 
cause of illness and death in infants and young chil-
dren (1). Human bocavirus (HBoV) was ﬁ  rst identiﬁ  ed in 
respiratory samples from children and was proposed to be 
pathogenic in humans (2). Subsequently, HBoV infections 
were reported in children with ARTI (1,3,4), and found in 
stool samples from children with gastroenteritis worldwide 
(5). In 2009, Kapoor et al. identiﬁ  ed another human parvo-
virus that was most closely related to HBoV and named it 
HBoV genotype 2 (HBoV2) (6). In this study we examined 
its presence in nasopharyngeal aspirates (NPAs) from chil-
dren hospitalized with ARTI. 
The Study
NPA samples were collected from 235 children hos-
pitalized with ARTI at the First Hospital of Lanzhou Uni-
versity, Gansu Province, China during December 2007–
November 2008. All patients were <15 years of age, and 
informed consent was obtained from their parents. Demo-
graphic data and clinical ﬁ  ndings were recorded. The study 
protocol was approved by the hospital ethics committee.
DNA and RNA were extracted from the NPAs by us-
ing QIAamp DNA and QIAamp viral RNA mini kits (QIA-
GEN, Beijing, China). The cDNA sample was synthesized 
by using random hexamer primers. A standard reverse tran-
scription–PCR was used to screen for human rhinovirus, 
respiratory synctial virus (RSV), inﬂ  uenza virus A, inﬂ  uen-
za virus B, parainﬂ  uenza virus 1–3, human metapneumovi-
rus, human coronavirus (HCoV)-NL63, and HCoV-HKU1, 
and PCR method was used to screen for adenovirus (ADV) 
(7–11).To screen for HBoV, PCR was performed by using 
primers 188F and 542R, as described by Allander et al. (2). 
For HBoV2, nested PCR was performed with sf1/sr1 and 
sf2/sr2 primers, which ampliﬁ  ed a 455-bp fragment of the 
partial NS1 gene, as described (6).
In addition, we designed HBoV2 forward (SN1: 5′-
ACCAGTGGGAGAACCACAAG-3′) and reverse (SN2: 
5′-GGCATTTGTTTCCATGCTTT-3′) primers, which 
produced a 563-bp fragment of the NP1 gene of HBoV2. 
Positive and negative controls were included for each 
PCR. Puriﬁ   ed PCR products were sequenced by using 
SinoGenoMax. ClustalX (ftp://ftp-igbmc.u-strasbg.fr/pub/
ClustalX) was used to align the obtained sequences with 
sequences available in GenBank.
In total, 260 viruses were identiﬁ  ed in 196 (83.4%) 
of the 235 children. Using nested PCR, we found 21 
positive specimens; further nucleotide sequence analysis 
showed that 10 (4.3%) were HBoV2 and 11 were HBoV 
(Figure, panel A). All 11 HBoV strains detected by using 
HBoV2 nested-PCR were included in the 18 HBoV-pos-
itive patients as determined by PCR using primers 188F 
and 542R. Of the 10 HBoV2-positive patients, 7 (70%) 
were co-infected with other respiratory viruses, including 
4 patients with RSV. Of the 18 HBoV-positive patients, 
12 (66.7%) displayed co-infections. There were no statis-
tically signiﬁ  cant differences in the HBoV2 and HBoV 
detection (p = 0.119 by χ2 test) and co-infection (p = 1.000 
by Fisher exact test) rates.
Of the 10 HBoV2-positive patients, 9 were male and 1 
was female (χ2 = 1.957, p = 0.162). The median age was 8.5 
months, and 9/10 (90%) were <3 years old. HBoV2 infec-
tions were detected throughout the year. Of the 18 patients 
who were HBoV positive, 11 were male and 7 were female 
(χ2 = 0.084, p = 0.772). The median age of patients was 
11.5 months, and 16/18 (88.9%) were <3 years old.
HBoV infections were detected in every month except 
August, with peaks in December (3 cases) and January (4 
cases). The main diagnoses of the 3 patients with HBoV2 
monoinfection were acute asthmatic bronchopneumonia, 
bronchopneumonia, and acute upper respiratory tract infec-
tion in 1 patient each. For the 6 patients with HBoV monoin-
fection, the main diagnoses were acute asthmatic broncho-
pneumonia (4 cases) and bronchopneumonia (2 cases). The 
clinical signs and symptoms of HBoV2 and HBoV positive 
patients included cough, fever, sputum production, crack-
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les, wheezing, rhinorrhea, cyanosis, vomiting, and diarrhea 
(Table 1). For patients with HBoV2 monoinfection, the 
median hospital stay was 11.3 days (range 4–23 days), and 
2 had underlying illnesses (idiopathic pulmonary hemosi-
derosis and iron deﬁ  ciency anemia). The chest radiograph 
of 1 patient showed upper middle zone air-space shadows. 
For patients with HBoV monoinfection, the median hospi-
tal stay was 7.8 days (range 6–10 days), and none had un-
derlying illnesses. Chest radiographs of 2 patients showed 
shadows in the left lung zone.
Ten HBoV2 NS-1 sequences (455 bp) shared 98%–
99% and 95%–96% nucleotide sequence identity and 
99%–100% and 98%–99% deduced amino acid sequence 
identity with HBoV2 strain PK-2255 (FJ170279) and 
HBoV2 strain W153 (EU082213), respectively; These se-
quences also shared 81%–82% and 83.3%–84.4% nucle-
otide sequence identity and 90% and 88% deduced amino 
acid sequence identity with the HBoV prototype strain ST1 
or ST2 (DQ000495 and DQ000496) and human bocavirus 
3 strain W471 (EU918736), respectively. The 4 HBoV2 
NP-1 sequences shared 98%–99% and 97.6%–98.3% nu-
cleotide sequence identity and 98%–100% and 97%–100% 
deduced amino acid sequence identity with HBoV2 strain 
PK-2255 and HBoV2 strain W153, respectively, and 
shared 74%–78% and 69.7%–70.3% nucleotide sequence 
identity and 69%–73% and 58%–62% deduced amino acid 
sequence identity with the prototype strain ST1 or ST2 and 
human bocavirus 3 strain W471, respectively. The nucle-
otide and deduced amino acid sequences of NS-1 and NP-1 
shared high identities (>97%) with the HBoV2 and HBoV 
sequences (Table 2). Phylogenetic analysis indicated that 
HBoV2 is more closely related to HBoV (Figure).
Conclusions
Using nested PCR and sequencing, we identiﬁ  ed 
HBoV2 infections in 10 (4.3%) of 235 NPAs from children 
hospitalized with ARTI. Most of the patients were <3 years 
old. In HBoV2-positive patients, co-infection was high 
(70%), with RSV being the most common co-pathogen. 
Primers SN1 and SN2 were designed to detect the NP1 gene 
in the 10 HBoV2-positive patients. However, only 4 gave 
positive results, which occurred because of the low PCR 
sensitivity with this pair of primers and because the NP1 
gene of HBoV2 is divergent, as described (6). Furthermore, 
as previous studies (6,12) pointed out, potential recombina-
tion upstream from the NP1 gene may explain the lower de-
tection. Phylogenetic analysis showed that the NS-1 region 
of the HBoV2 strain (LZ480 and LZ578) clustered closely 
with that of the HBoV2 PK-2255 strain (FJ170279), and 
the NP-1 region clustered closely with that of the HBoV2 
W153 strain (EU082213), suggesting potential recombina-
tion in the HBoV2 strains (Figure). In addition, 11 HBoV 
sequences were ampliﬁ  ed by using nested-PCR for HBoV2. 
In the future, HBoV2-speciﬁ  c primers should be designed 
to investigate the prevalence of HBoV2 and its potential 
association with disease.
We found no difference in the clinical symptoms or 
length of hospital stay between the groups with HBoV2 and 
HBoV monoinfection, as well as between the groups with 
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Figure. Phylogenetic analysis of A) the partial nonstructural 
protein 1 (NS1) nucleotide sequences (412 bp) and B) the partial 
nucleoprotein 1 (NP1) nucleotide sequences (256 bp) of human 
bocavirus 2 (HBoV2), Gansu Province, People’s Republic of China. 
The phylogenetic trees were constructed by the neighbor-joining 
method using MEGA 3.1 (www.megasoftware.net), and bootstrap 
values were determined for 1,000 replicates. Bootstrap values 
>50% are shown at the branching points. Human bocavirus (HBoV) 
and HBoV2 reference sequences are indicated by circles and 
squares, respectively. Bovine parvovirus (BPV), cytomegalovirus 
(CMV), and human parvovirus B19 (B19) reference sequences 
are indicated by inverted triangles. Scale bars indicate nucleotide 
substitutions per site. Reference sequences were obtained from 
GenBank (accession nos. DQ000495, DQ000496, EF450717, 
EU082213, EU918736, EU984232, FJ170278, FJ170279, 
FJ170280, NC001540, NC004442, and NC000883). Sequences 
generated in this study were deposited in GenBank under accession 
nos. FJ911558–FJ911600.HBoV2 monoinfection and HBoV2 co-infection (Table 1). 
Statistical analysis indicated that HBoV2 and HBoV co-
infection obviously did not correlate with disease severity 
(data not shown). Two of 3 patients with HBoV2 monoin-
fection had diarrhea with no vomiting (Table 1), and only 1 
of 10 patients who were HBoV2 positive vomited. Further 
investigation is needed to exclude oral or inhaled gastric 
viruses as possible sources of NPA-associated HBoV2. 
Phylogenetic analysis showed a high degree of similarity 
between HBoV2 sequences found in China and those in 
other areas (Figure). Our results suggest that like HBoV, 
HBoV2 is distributed worldwide and may be associated 
with respiratory and enteric diseases. Additional studies 
are needed to conﬁ  rm the association between human bo-
cavirus species (HBoV2 and HBoV) and respiratory tract 
infections or other diseases. 
Acknowledgments
We thank Xin-Hui Yuan, Yu-Ning Li , and Rong-Fang 
Zhang for their assistance in this study.
This work was partly supported from “973” National Key 
Basic Research Program of China (grant no. 2007CB310500).
Ms Song is a medical student in the Department of Pediat-
rics, First Hospital of Lanzhou University. Her research interests 
are the etiology of respiratory tract infections of children.
References
  1.   Qu XW, Duan ZJ, Qi ZY, Xie ZP, Gao HC, Liu WP, et al. Human 
bocavirus infection, People’s Republic of China. Emerg Infect Dis. 
2007;13:165–8. DOI: 10.3201/eid1301.060824
DISPATCHES
326  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 2, February 2010
Table 1. Comparison of clinical characteristics among different groups of children with acute respiratory infections, Gansu Province, 
China* 
p values
Characteristic 
Group 1,  
n = 3 
Group 2, 
n = 7 
Group 3, 
n = 6 
Group 4, 
n = 12 
Group 1 vs. 
Group 2 
Group 3 vs. 
Group 4 
Group 1 vs. 
Group 3 
Male sex  3 (100)  6 (85.7)  3 (50)  8 (66.7)  0.499†  0.145†  1.000† 
Age <3 y  3 (100)  6 (85.7)  6 (100)  10 (83.3)  1.000†  0.307† 1.000† 
Median duration of hospitalization, 
d (range) 
11.3 (4–23)  9 (8–11)  7.8 (6–10)  10.3 (5–20)  0.492†  0.187‡  1.000‡ 
No.  underlying  diseases  2 1 0 1  0.183†    
Clinical  diagnosis            
  AURI  1 (33.3)  0  0  1 (8.3)       
 Suppurative  tonsillitis  0  0  0  1(8.3)       
  Acute asthmatic  
 bronchopneumonia 
1 (33.3)  4 (57.1)  4 (66.7)  7 (58.3)  0.500§  0.572§  0.405§ 
  Bronchopneumonia  1 (33.3)  1 (14.3)  2 (33.3)  3 (25.0)  0.533§  0.561§  0.774§ 
  Acute bronchitis  0  2 (28.6)  0  0       
Clinical  signs            
  Fever   2 (66.7)  5 (71.4)  2 (33.3)  7 (58.3)  0.708§  0.310§  0.405§ 
  Cough  2 (66.7)  5 (71.4)  5 (83.3)  10 (83.3)  0.708§  0.730§ 0.583§ 
  Wheeze  1 (33.3)  4 (57.1)  4 (66.7)  7 (58.3)  1.000§  0.572§ 0.405§ 
 Rhinorrhea  2 (66.7)  2 (28.6)  2 (33.3)  5 (41.7)  0.500§  0.572§  0.405§ 
 Sputum  production  1 (33.3)  5 (71.4)  5 (83.3)  4 (33.3)  0.500§  0.066§  0.226§ 
 Crackles  2 (66.7)  6 (85.7)  6 (100)  7 (58.3)  1.000§     
  Vomiting  0  1 (14.3)  1 (16.7)  0       
  Diarrhea  2 (66.7)  1 (14.3)  1 (16.7)  1 (8.3)  0.183§  0.569§  0.226§ 
*Values are no. (%) children except as indicated. HBoV, human bocavirus; AURI, acute upper respiratory tract infection. Group 1, HBoV2 monoinfection; 
Group 2, HBoV2 co-infection; Group 3, HBoV1 monoinfection; Group 4, HBoV1 co-infection. 
†By Ȥ
2 test. 
‡By Mann-Whitney test. 
§By Fisher exact test. 
Table 2. Nucleotide and amino acid sequence comparisons among and between human bocaviruses, Gansu Province, China*  
NS1 sequence identity, %  NP1 sequence identity, % 
Virus comparison  Nucleotide Amino acid  Nucleotide Amino acid 
With HBoV2 PK-2255 sequence  98–99 99–100 98–99 98–100
With HBoV2 strain W153 sequence  95–96 98–99 97.6–98.3 97–100
With the HBoV prototype strain ST1 or ST2 sequence  81–82 90 74–78 69–73
With HBoV 3 strain W471 sequence  83.3–84.4 88 69.7–70.3 58–62
Among the HBoV2 sequence  97–99 98 98–100 99–100
Among the HBoV sequence  97–98 99 97–100 98–100
*HBoV, human bocavirus; NS1, nonstructural protein 1; NP1, nucleoprotein 1. Novel Human Bocavirus in Children
  2.   Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell 
A, Andersson B, et al. Cloning of a human parvovirus by molecular 
screening of respiratory tract samples. Proc Natl Acad Sci U S A. 
2005;102:12891–6. DOI: 10.1073/pnas.0504666102
  3.   Bastien N, Brandt K, Dust K, Ward D, Li Y. Human bocavirus infec-
tion, Canada. Emerg Infect Dis. 2006;12:848–50.
  4.   Foulongne V, Olejnik Y, Perez V, Elaerts S, Rodiere M, Segondy 
M, et al. Human bocavirus in French children. Emerg Infect Dis. 
2006;12:1251–3.
  5.   Cheng WX, Jin Y, Duan ZJ, Xu ZQ, Qi HM, Zhang Q, et al. Hu-
man bocavirus in children hospitalized for acute gastroenteri-
tis: a case–control study. Clin Infect Dis. 2008;47:161–7. DOI: 
10.1086/589244
  6.   Kapoor A, Slikas E, Simmonds P, Chieochansin T, Naeem A, Shau-
kat S, et al. A newly identiﬁ  ed bocavirus species in human stool. J 
Infect Dis. 2009;199:196–200. DOI: 10.1086/595831
  7.   Bastien N, Robinson JL, Tse A, Lee BE, Hart L, Li Y. Human coro-
navirus NL-63 infections in children: a 1-year study. J Clin Micro-
biol. 2005;43:4567–73. DOI: 10.1128/JCM.43.9.4567-4573.2005
  8.   Bellau-Pujol S, Vabret A, Legrand L, Dina J, Gouarin S, Petitjean-
Lecherbonnier J, et al. Development of three multiplex RT-PCR as-
says for the detection of 12 respiratory RNA viruses. J Virol Meth-
ods. 2005;126:53–63. DOI: 10.1016/j.jviromet.2005.01.020
  9.   Hierholzer JC, Halonen PE, Dahlen PO, Bingham PG, McDonough 
MM. Detection of adenovirus in clinical specimens by polymerase 
chain reaction and liquid-phase hybridization quantitated by time-
resolved ﬂ  uorometry. J Clin Microbiol. 1993;31:1886–91.
10.   Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingster-
haus JM, Edwards KM, et al. Human metapneumovirus and lower 
respiratory tract disease in otherwise healthy infants and children. N 
Engl J Med. 2004;350:443–50. DOI: 10.1056/NEJMoa025472
11.   Woo PC, Lau SK, Tsoi HW, Huang Y, Poon RW, Chu CM, et al. 
Clinical and molecular epidemiological features of coronavirus 
HKU1-associated community-acquired pneumonia. J Infect Dis. 
2005;192:1898–907. DOI: 10.1086/497151
12.   Arthur JL, Higgins GD, Davidson GP, Givney RC, Ratcliff RM. A 
novel bocavirus associated with acute gastroenteritis in Australian 
children. PLoS Pathog. 2009;5:e1000391. DOI: 10.1371/journal.
ppat.1000391
Address for correspondence: Zhao-jun Duan, Department of Viral 
Diarrhea, National Institute for Viral Disease Control and Prevention, 
China Center for Disease Control, 100 Ying-Xin St, Xuan-Wu District, 
Beijing 100052, People’s Republic of China; email: zhaojund@126.com
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 2, February 2010  327 